Overview
Azithromycin is a broad-spectrum macrolide antibiotic renowned for its unique pharmacokinetic properties, which allow for a short and convenient dosing schedule. It is highly effective against a wide range of bacteria and is frequently prescribed for upper and lower respiratory tract infections, skin infections, and certain sexually transmitted diseases like chlamydia.

Mechanism of Action
Azithromycin exerts its antibacterial effects by binding to the 50S ribosomal subunit of susceptible microorganisms. This binding action fundamentally interferes with and inhibits the bacteria’s ability to synthesize essential proteins. Without these proteins, the bacteria cannot grow, replicate, or survive, effectively halting the progression of the infection.

Dosage and Administration
One of its major advantages is the short treatment course. For many common respiratory infections, the typical adult regimen is 500 mg on the first day, followed by 250 mg once daily for the next 4 days (a 5-day course), or 500 mg daily for 3 days. Despite the short course, the drug tissue half-life is exceptionally long, meaning the medication continues to actively fight the infection in the body for days after the last dose is taken.

Side Effects
Azithromycin is generally well-tolerated, but gastrointestinal disturbances are the most common side effects, including nausea, vomiting, abdominal pain, and diarrhea. Less commonly, it can cause changes in taste or mild skin rashes. A rare but serious cardiovascular risk associated with macrolides is the prolongation of the QT interval, which can lead to potentially fatal heart arrhythmias.

Contraindications and Precautions
It is contraindicated in patients with a known hypersensitivity to azithromycin, erythromycin, or any other macrolide antibiotic. Caution is strongly advised in patients with a history of prolonged QT interval, ongoing proarrhythmic conditions, or severe hepatic impairment, as the drug is primarily metabolized by the liver.

Pregnancy and Lactation
Azithromycin is generally considered safe for use during pregnancy when a macrolide is clinically indicated. It is excreted into human breast milk, but is generally considered acceptable to use during breastfeeding, though the infant should be monitored for potential side effects like diarrhea.